George K. Ng - Chief Executive Officer, Director at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
PCSA on Nasdaq
All Insider Reports
All Insider Reports

Sponsored

George K. Ng - trading volume in the past year for Processa Pharmaceuticals, Inc.

Holdings reported by George K. Ng for Processa Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 87,200 $18,312 $0.2100 24 Jul 2025 George Ng IRRA FBO: George Ng
Common Stock 3,488 $10,045 $2.88 31 Mar 2026 George Ng IRRA FOB George Ng
Common Stock 3,649 $9,250 $2.54 31 Mar 2026 Direct
Warrants 43,600 $9,156 $0.2100 24 Jul 2025 George Ng IRRA FBO: George Ng Common Stock 43,600
Common Stock 800 $2,304 $2.88 31 Mar 2026 Ng Cha Family Trust
Stock Options (Right to Buy) 768,000 01 Oct 2025 Direct Common Stock
Restricted Stock Units 256,000 01 Oct 2025 Direct Common Stock

Transactions reported by George K. Ng for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.